Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

A Study to Determine if Tetrix Cream Impedes the Resolution of Experimentally Induced Allergic Contact Dermatitis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00643214

Enrollment

Registered

2008-03-26

Start date

2007-10-31

Completion date

2007-11-30

Last updated

2008-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Tetrix Cream, Antigen reaction, effect on healing, To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing

Brief summary

To determine if Tetrix Cream,, when applied to the skin lesions on patients with contact dermatitis, slows or interferes with the healing of the lesions.

Interventions

DEVICETetrix

Twice daily topical application

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Normal subjects with sensitivity to nickel.

Exclusion criteria

* Under 18 years of age.

Design outcomes

Primary

Measure	Time frame
Clearing of signs and symptoms of contact dermatitis	10 days after induction of lesion and start of treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026